NATH Q4 2024 Earnings EPS of 096 Signals Resilient Profitability ADXN Q1 2024 Earnings Biotech Reports Net Loss Amid Clinical Pipeline Progress WGRX Q1 2026 Earnings EPS Loss of 007 Triggers Sharp Decline POSCO Holdings PKX Q4 2025 Earnings Significant EPS Miss Driven by Negative Surprise ULBI Q1 2026 Earnings Earnings Miss but Stock Gains Signaling Investor Optimism PRH Q1 2026 Earnings EPS Surges 154 Above Estimates Positive Market Response